Research Platform Presentations

A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) 

 
 View more SIDPEC Activities
 

NOTE: If you attended this live CE activity that was held on October 1, 2019 at the SIDP Annual Meeting AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-19-478-L01-P), you are NOT eligible to also receive CE credit for this home-study activity.

Description

These five projects represent some of the exceptional research being conducted by SIDP members. Presentations include the following: Bedside Nurses Improve Antimicrobial Stewardship and Infection Prevention Outcomes; Eosinopenia and Binary Toxin Increases Mortality in Hospitalized Patients with Clostridioides Difficile Infection; Impact of Vancomycin Area Under Curve on Persistent Methicillin-Resistant Staphylococcus aureus Bloodstream Infections; Activity of Fosfomycin and Frequency of Nonsusceptible Inner Colonies During Susceptibility Testing of an International Collection of Clinical Pseudomonas aeruginosa Isolates; Comparison of Diagnosis and Prescribing Practices Between Virtual Visits and Office Visits for Sinusitis Within Primary Care Practice.

This is a featured CE activity on the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) website. SIDPEC is the educational hub of the Society of Infectious Diseases Pharmacists (SIDP). The SIDPEC portal provides educational activities on infectious disease pharmacotherapy for clinical pharmacists, health‐systems pharmacists, community pharmacists, and other allied‐health disciplines.

Learning Objectives

The target audience for this activity is pharmacists. At the completion of this activity, the participant will be able to:

  • Discuss results of bedside nurses in stewardship.
  • Discuss research results about eosinopenia and binary toxin in C. difficile infection.
  • Discuss research about persistent MRSA bloodstream infections and vancomycin AUC.
  • Discuss susceptibility results of fosfomycin against Pseudomonas aeruginosa.
  • Discuss the efficacy of virtual visits for the treatment of sinusitis.

Faculty

David Ha, PharmD, BCIDP
Keck Graduate Institute

Travis Carlson, PharmD
University of Houston College of Pharmacy

Sara Alosaimy, PharmD, BCPS
Wayne State University

Elizabeth Smith, PharmD Student
University of Minnesota

Lisa Dumkow, PharmD, BCPS, BCIDP
Mercy Health

Accreditation

Release Date: 10-1-2019
Expiration Date: 10-1-2022

Pharmacists

ACPE LogoThis activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-19-478-H01-P has been assigned to this home-study knowledge-based activity (initial release date 10-1-2019). This activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. The faculty have no relevant commercial or financial relationships to disclose.

Funding

This activity is supported by an educational grant from Shionogi.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.